Hi Warren,
I don't mean any disrespect, can you please post your link to the DJ article you posted. I do my DD because this is the "Internet." Unless DJ yanked it, I cannot find it so I cannot confirm it. All I can find is the article below plus the link. NO where does it mention a March date launch date.
Also a search on author "Paul Haavardsrud" doesn't yield any such article.
Thanks for bringing it to our attention.
Index:
dowjones.work.com
Article:
dowjones.work.com
Dimethaid Gets Final UK Marketing OK For Pennsaid
Monday November 27 8:11am
Source: Dow Jones
TORONTO -(Dow Jones)- Dimethaid Research Inc. (T.DMX) has received final marketing
approval from the U.K. Medicines Control Agency for its PENNSAID Lotion, which is used to
treat osteoarthritis.
In a news release, Dimethaid said it will immediately seek approvals from other European
Union countries. Under the Mutual Recognition procedure prevailing in the EU, the U.K. will
act as agent for other EU member states, who can recognize this approval and issue their
own authorizations. Member countries include Germany, France and Italy, three of the largest
pharmaceutical markets in the world, it noted.
The company said this first approval of PENNSAID in an important market "is a significant
milestone for Dimethaid," noting there are about 7 million osteoarthritis sufferers in the U.K.
Osteoarthritis, or degenerative joint disease, is characterized by the breakdown of cartilage
that normally cushions and protects joints from impact. As the cartilage erodes, sufferers
experience considerable pain and loss of function.
Dimethaid said it expects the commercial launch of PENNSAID "to be an important source of
revenue for Dimethaid in 2001 and beyond." It didn't provide a revenue projection.
Dimethaid is a pharmaceutical company.
Company Web Site: dimethaid.com
-Carolyn M. King, Dow Jones Newswires; 416-306-2100
(This story was originally published by Dow Jones Newswires)
Copyright (c) 2000 Dow Jones & Company, Inc.
All Rights Reserved |
